These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 20693542

  • 1. Peripheral neuropathy in adult type 1 Gaucher disease: a 2-year prospective observational study.
    Biegstraaten M, Mengel E, Maródi L, Petakov M, Niederau C, Giraldo P, Hughes D, Mrsic M, Mehta A, Hollak CE, van Schaik IN.
    Brain; 2010 Oct; 133(10):2909-19. PubMed ID: 20693542
    [Abstract] [Full Text] [Related]

  • 2. Are symptoms of peripheral neuropathy more prevalent in patients with Gaucher disease?
    Halperin A, Elstein D, Zimran A.
    Acta Neurol Scand; 2007 Apr; 115(4):275-8. PubMed ID: 17376127
    [Abstract] [Full Text] [Related]

  • 3. [Peripheral neuropathy associated with chronic obstructive pulmonary disease].
    Poza JJ, Martí-Massó JF.
    Neurologia; 1997 Nov; 12(9):389-94. PubMed ID: 9471176
    [Abstract] [Full Text] [Related]

  • 4. The at-risk foot concerns not only patients with diabetes mellitus.
    Pataky Z, Herrmann FR, Regat D, Vuagnat H.
    Gerontology; 2008 Nov; 54(6):349-53. PubMed ID: 18446046
    [Abstract] [Full Text] [Related]

  • 5. [Study of the onset and progression of peripheral neuropathy and hypertension in NIDDM].
    Jarmuzewska EA, Ghidoni A.
    Minerva Med; 2000 Nov; 91(1-2):1-15. PubMed ID: 10858728
    [Abstract] [Full Text] [Related]

  • 6. Miglustat (Zavesca) in type 1 Gaucher disease: 5-year results of a post-authorisation safety surveillance programme.
    Hollak CE, Hughes D, van Schaik IN, Schwierin B, Bembi B.
    Pharmacoepidemiol Drug Saf; 2009 Sep; 18(9):770-7. PubMed ID: 19507165
    [Abstract] [Full Text] [Related]

  • 7. Incidence of malignancies among patients with type I Gaucher disease from a single referral clinic.
    Zimran A, Liphshitz I, Barchana M, Abrahamov A, Elstein D.
    Blood Cells Mol Dis; 2005 Sep; 34(3):197-200. PubMed ID: 15885601
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Increased incidence of cancer in adult Gaucher disease in Western Europe.
    de Fost M, Vom Dahl S, Weverling GJ, Brill N, Brett S, Häussinger D, Hollak CE.
    Blood Cells Mol Dis; 2006 Sep; 36(1):53-8. PubMed ID: 16246599
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The clinical course of untreated Gaucher disease in 22 patients over 10 years: hematological and skeletal manifestations.
    Piran S, Roberts A, Patterson MA, Amato D.
    Blood Cells Mol Dis; 2009 Sep; 43(3):289-93. PubMed ID: 19793665
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. An open-label, noncomparative study of miglustat in type I Gaucher disease: efficacy and tolerability over 24 months of treatment.
    Pastores GM, Barnett NL, Kolodny EH.
    Clin Ther; 2005 Aug; 27(8):1215-27. PubMed ID: 16199246
    [Abstract] [Full Text] [Related]

  • 17. Peripheral neuropathy in myotonic dystrophy: electrophysiological and clinical features.
    Logullo F, Censori B, Danni M, Del Pesce M, Di Bella P, Provinciali L.
    Electromyogr Clin Neurophysiol; 1992 Aug; 32(10-11):515-20. PubMed ID: 1332841
    [Abstract] [Full Text] [Related]

  • 18. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
    De Boeck K, Weren M, Proesmans M, Kerem E.
    Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.